AMG’s aggressive push into higher-fee alternatives through partnerships with HighBrook Investors and Garda Capital Partners signals confidence in its boutique…
Read More
Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025
Net sales increased 30% year-over-year to $129.4 million in 2025 Gross margin increased 250 bps year-over-year to 64.3% in 2025…
Read More
